Panagora Asset Management Inc Fibrogen Inc Transaction History

Panagora Asset Management Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$15.95 - $25.18 $136,037 - $214,760	-8,529 Reduced 20.03%	34,053 $635,000
Q4 2022 Feb 13, 2023	SELL	$13.27 - $17.73 $2.97 Million - $3.97 Million	-224,049 Reduced 84.03%	42,582 $682,000
Q3 2022 Nov 14, 2022	BUY	$11.4 - $14.6 $1.19 Million - $1.52 Million	104,005 Added 63.95%	266,631 $3.47 Million
Q2 2022 Aug 15, 2022	BUY	$7.94 - $12.96 $1.07 Million - $1.75 Million	134,906 Added 486.67%	162,626 $1.72 Million
Q1 2022 May 12, 2022	BUY	$12.02 - $16.79 $333,194 - $465,418	27,720 New	27,720 $333,000
Q3 2020 Nov 13, 2020	SELL	$40.47 - $45.5 $12,383 - $13,923	-306 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$36.98 - $48.45 $1,738 - $2,277	-47 Reduced 13.31%	306 $11,000
Q1 2019 May 15, 2019	SELL	$42.83 - $59.91 $107,931 - $150,973	-2,520 Reduced 87.71%	353 $19,000
Q4 2018 Feb 14, 2019	SELL	$37.97 - $60.16 $1.15 Million - $1.82 Million	-30,234 Reduced 91.32%	2,873 $133,000
Q3 2018 Nov 13, 2018	SELL	$56.3 - $67.25 $195,079 - $233,021	-3,465 Reduced 9.47%	33,107 $2.01 Million
Q2 2018 Aug 14, 2018	SELL	$44.9 - $64.95 $1.7 Million - $2.46 Million	-37,900 Reduced 50.89%	36,572 $2.29 Million
Q1 2018 May 15, 2018	SELL	$45.35 - $61.65 $5.91 Million - $8.04 Million	-130,359 Reduced 63.64%	74,472 $3.44 Million
Q4 2017 Feb 14, 2018	SELL	$41.95 - $60.1 $69,133 - $99,044	-1,648 Reduced 0.8%	204,831 $9.71 Million
Q3 2017 Nov 14, 2017	BUY	$33.4 - $53.9 $6.9 Million - $11.1 Million	206,479	206,479 $11.1 Million

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.